BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2109515)

  • 1. A comparative study of three oral contraceptives in Ibadan: Norinyl 1/35, Lo-Ovral and Noriday 1/50.
    Otolorin EO; Falase EA; Ladipo OA
    Afr J Med Med Sci; 1990 Mar; 19(1):15-22. PubMed ID: 2109515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
    Ayangade O; Akinyemi A
    Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative trials of low-dose combined oral contraceptives.
    Edelman DA; Kothenbeutel R; Levinski MJ; Kelly SE
    J Reprod Med; 1983 Mar; 28(3):195-200. PubMed ID: 6854550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized double blind study of two oral contraceptives.
    Sanhueza H; Sivin I; Kumar S; Kessler M; Carrasco A; Yee J
    Contraception; 1979 Jul; 20(1):29-48. PubMed ID: 477315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of 35 mcg and 50 mcg combined oral contraceptives: results from a multicenter clinical trial.
    McLaurin VL; Dunson BA; Dunson TR
    Contraception; 1991 Nov; 44(5):489-503. PubMed ID: 1797464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative clinical trial of Norinyl 1 + 35 versus Norinyl 1 + 50 in Merida, Yucatan, Mexico.
    de Cetina TC; Reyes LP; Gamboa LV; Dunson TR; Rowan AJ; Waszak CS; Weaver MB
    Adv Contracept; 1990 Jun; 6(2):125-39. PubMed ID: 2206018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The probability of side effects with ovral, norinyl 1/50 and norlestrin.
    Berger GS; Edelman DA; Talwar PP
    Contraception; 1979 Nov; 20(5):447-53. PubMed ID: 160860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of Norinyl 1/35 versus Norinyl 1/50 in Belgrade, Yugoslavia.
    Behilovic B; Rowan AJ
    Contraception; 1987 Nov; 36(5):515-26. PubMed ID: 3329079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives.
    Dunson TR; McLaurin VL; Aguayo EL; de Silva P; Calventi V; Gerais AS; Serani RG
    Contraception; 1993 Jun; 47(6):515-25. PubMed ID: 8334888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of two low-dose combined oral contraceptives: results from a multicenter trial.
    Dunson TR; McLaurin VL; Israngkura B; Leelapattana B; Mukherjee R; Perez-Palacios G; Saleh AA
    Contraception; 1993 Aug; 48(2):109-19. PubMed ID: 8403908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of Norinyl and Brevicon in three sites in Sri Lanka.
    Basnayake S; de Silva SV; Miller PC; Rogers S
    Contraception; 1983 May; 27(5):453-64. PubMed ID: 6884024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative clinical trial of Norinyl 1/35 versus Brevicon in Rio Clara, Brazil.
    Albuquerque LA; Albuquerque EG; Waszak CS; Rowan AJ; Barthlow D
    Contraception; 1988 Nov; 38(5):525-39. PubMed ID: 3058383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO.
    Poindexter AN; Burkman R; Fisher AC; LaGuardia KD
    Int J Fertil Womens Med; 2003; 48(4):163-72. PubMed ID: 13677549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of Norinyl 1/35 versus Brevicon in Panama City, Panama.
    Moreno J; Rowan AJ
    Contraception; 1987 Dec; 36(6):615-25. PubMed ID: 3446438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A crossover pill study among Sudanese women.
    Gerais AS; Rushwan H
    Int J Gynaecol Obstet; 1985 Jun; 23(3):229-33. PubMed ID: 2865187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and panic disorder.
    Deci PA; Lydiard RB; Santos AB; Arana GW
    J Clin Psychiatry; 1992 May; 53(5):163-5. PubMed ID: 1592843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of the side effects of switching from one oral contraceptive to another.
    Edelman DA; Kothenbeutel R; Levinski MJ; Talwar PP
    Int J Gynaecol Obstet; 1976; 14(5):397-400. PubMed ID: 15904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic study of blood in women who had used oral contraceptives.
    Fridrichová I
    Neoplasma; 1990; 37(5):545-53. PubMed ID: 1700312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20.
    Hampton RM; Short M; Bieber E; Bouchard C; Ayotte N; Shangold G; Fisher AC; Creasy GW
    Contraception; 2001 Jun; 63(6):289-95. PubMed ID: 11672549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.